Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 399

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome

Glueck, C.J, Papanna, Ranganath, Wang, Ping, Goldenberg, Naila, Sieve-Smith, Luann·2003·Metabolism

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0026-0495(03)00104-5

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 32

  1. Haffner, 1992, Prospective analysis of the insulin-resistance syndrome (syndrome X), Diabetes, 41, 715, 10.2337/diabetes.41.6.715 · DOI
  2. Trovisan, 1998, Syndrome X and mortality a population-based study, Am J Epidemiol, 14B, 958, 10.1093/oxfordjournals.aje.a009572 · DOI · Paper page
  3. Ford, 2002, Prevalence of the metabolic syndrome among US adults, JAMA, 287, 356, 10.1001/jama.287.3.356 · DOI · Paper page
  4. Grundy, 1999, Hypertriglyceridemia, insulin resistance, and the metabolic syndrome, Am J Cardiol, 83, 25F, 10.1016/S0002-9149(99)00211-8 · DOI · Paper page
  5. Hansson, 1998, Therapy of hypertension and metabolic syndrome, Blood Press, 20, 10.1080/080370598438438 · doi:10.1080/080370598438438
  6. Moller, 2001, New drug targets for type 2 diabetes and the metabolic syndrome, Nature, 414, 821, 10.1038/414821a · DOI · Paper page
  7. Pasquali, 1999, The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment, Clin Endocinol, 50, 517, 10.1046/j.1365-2265.1999.00701.x · DOI · Paper page
  8. Glueck, 1999, Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome, Metabolism, 48, 511, 10.1016/S0026-0495(99)90113-0 · DOI · Paper page
  9. Knochenhauer, 1998, Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States, J Clin Endocrinol Metab, 83, 3078, 10.1210/jc.83.9.3078 · DOI · Paper page
  10. Fleming, 2002, Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double-blind, placebo-controlled trial, J Clin Endocrinol Metab, 87, 569, 10.1210/jc.87.2.569 · DOI · Paper page
  11. Glueck, 1999, Contribution of fasting hyperinsulinemia to prediction of atherosclerotic cardiovascular disease in 239 hyperlipidemic patients, Metabolism, 48, 1427, 10.1016/S0026-0495(99)90156-7 · DOI
  12. Glueck, 2002, Pregnancy outcomes among women with polycystic ovary syndrome, Hum Reprod, 17, 2858, 10.1093/humrep/17.11.2858 · DOI · Paper page
  13. Glueck, 2002, Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome, Fertil Steril, 77, 520, 10.1016/S0015-0282(01)03202-2 · DOI · Paper page
  14. Ferriman, 1961, Clinical Assessment of body hair growth in women, J Clin Endocrinol Metab, 21, 1440, 10.1210/jcem-21-11-1440 · DOI · Paper page
  15. Lobo, 2000, The importance of diagnosing the polycystic ovary syndrome, Ann Intern Med, 132, 989, 10.7326/0003-4819-132-12-200006200-00010 · DOI · Paper page
  16. Talbott, 1995, Coronary heart disease risk factors in women with polycystic ovary syndrome, Arterioscl Thromb Vasc Biol, 15, 821, 10.1161/01.ATV.15.7.821 · DOI · Paper page
  17. Talbott, 2001, Cardiovascular risk in women with polycystic ovary syndrome, Ob Gyn Clin N Am, 28, 111, 10.1016/S0889-8545(05)70189-3 · DOI
  18. Loucks, 2000, Do polycystic ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?, Fert Steril, 74, 547, 10.1016/S0015-0282(00)00695-6 · DOI
  19. Paradisi, 2001, Polycystic ovary syndrome is associated with endothelial dysfunction, Circulation, 103, 1410, 10.1161/01.CIR.103.10.1410 · DOI · Paper page
  20. Yarali, 2001, Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome, Fertil Steril, 76, 511, 10.1016/S0015-0282(01)01937-9 · DOI · Paper page
  21. Diamanti-Kandarakis, 2001, Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy, J Clin Endocrinol Metab, 86, 4666, 10.1210/jc.86.10.4666 · DOI
  22. Guzick, 1996, Carotid atherosclerosis in women with polycystic ovary syndrome, Am J Obstet Gynecol, 174, 1224, 10.1016/S0002-9378(96)70665-8 · DOI · Paper page
  23. Dahlgren, 1992, Polycystic ovary syndrome and risk for myocardial infarction, Acta Obstet Gynecol Scand, 71, 559, 10.3109/00016349209006227 · DOI · Paper page
  24. Legro, 2002, Self-selected women with polycystic ovary syndrome are reproductively and metabolically abnormal and undertreated, Fertil Steril, 78, 51, 10.1016/S0015-0282(02)03153-9 · DOI
  25. Korhonen, 2001, Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome, Am J Obstet Gynecol, 184, 289, 10.1067/mob.2001.109596 · DOI
  26. Pan, 1997, Effects of diet and exercise in prevention NIDDM in people with impared glucose tolerance, Diabetes Care, 20, 537, 10.2337/diacare.20.4.537 · DOI · Paper page
  27. Freemark, 2001, Effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes, Pediatrics, 107, E55, 10.1542/peds.107.4.e55 · DOI · Paper page
  28. Kay, 2001, Beneficial effects of metformin in morbidly obese adolescents, Metabolism, 50, 1457, 10.1053/meta.2001.28078 · DOI · Paper page
  29. Glueck, 2002, Treatment of polycystic ovary syndrome with insulin-lowering agents, Exp Opin Pharmacother, 3, 177
  30. Despres, 1996, Hyperinsulinemia as an independent risk factor for ischemic heart disease, N Engl J Med, 334, 952, 10.1056/NEJM199604113341504 · DOI · Paper page
  31. Folsom, 1997, A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes, Diabetes Care, 209, 935, 10.2337/diacare.20.6.935 · DOI · Paper page
  32. Kuusisto, 2001, Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men, Diabetes Care, 24, 1629, 10.2337/diacare.24.9.1629 · DOI

Cited by

See all 399

Metadata

Authors
Glueck, C. J., Papanna, R., Wang, P., Goldenberg, N., & Sieve-Smith, L.
Venue
Metabolism
Publisher
Elsevier BV
Published
2003-07
Volume
52
Issue
7
Pages
908-915
ISSN
0026-0495 (ISSN-L)
OpenAlex
W2067094952
Cited by
399
References
15
FWCI
18.84
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. https://app.cochat.ai/papers/10.1016/s0026-0495(03)00104-5
The paper
Glueck, C. J., Papanna, R., Wang, P., Goldenberg, N., & Sieve-Smith, L. (2003). Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism. https://doi.org/10.1016/s0026-0495(03)00104-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.